Swiss National Bank’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-122,900
| Closed | -$2.39M | – | 2570 |
|
|
2018
Q1 | $2.39M | Buy |
122,900
+6,000
| +5% | +$118K | ﹤0.01% | 1522 |
|
|
2017
Q4 | $1.95M | Hold |
116,900
| – | – | ﹤0.01% | 1654 |
|
|
2017
Q3 | $2.37M | Hold |
116,900
| – | – | ﹤0.01% | 1503 |
|
|
2017
Q2 | $1.88M | Buy |
116,900
+15,500
| +15% | +$229K | ﹤0.01% | 1625 |
|
|
2017
Q1 | $1.28M | Hold |
101,400
| – | – | ﹤0.01% | 1859 |
|
|
2016
Q4 | $1.34M | Hold |
101,400
| – | – | ﹤0.01% | 1837 |
|
|
2016
Q3 | $2.4M | Sell |
101,400
-2,400
| -2% | -$64.5K | ﹤0.01% | 1382 |
|
|
2016
Q2 | $2.99M | Sell |
103,800
-6,400
| -6% | -$209K | ﹤0.01% | 1203 |
|
|
2016
Q1 | $3.41M | Buy |
110,200
+20,300
| +23% | +$714K | 0.01% | 1095 |
|
|
2015
Q4 | $3.84M | Hold |
89,900
| – | – | 0.01% | 923 |
|
|
2015
Q3 | $3.17M | Buy |
89,900
+11,700
| +15% | +$527K | 0.01% | 1027 |
|
|
2015
Q2 | $3.59M | Buy |
78,200
+1,600
| +2% | +$75.9K | 0.01% | 940 |
|
|
2015
Q1 | $3.59M | Buy |
76,600
+1,100
| +1% | +$43.8K | 0.01% | 949 |
|
|
2014
Q4 | $2.39M | Buy |
75,500
+2,200
| +3% | +$64.4K | 0.01% | 1146 |
|
|
2014
Q3 | $1.74M | Sell |
73,300
-1,300
| -2% | -$33.3K | 0.01% | 1287 |
|
|
2014
Q2 | $2.24M | Hold |
74,600
| – | – | 0.01% | 1185 |
|
|
2014
Q1 | $1.97M | Buy |
74,600
+16,700
| +29% | +$417K | 0.01% | 1217 |
|
|
2013
Q4 | $1.46M | Buy |
57,900
+600
| +1% | +$13.4K | 0.01% | 1248 |
|
|
2013
Q3 | $1.18M | Sell |
57,300
-3,100
| -5% | -$64K | ﹤0.01% | 1338 |
|
|
2013
Q2 | $1.21M | Buy |
+60,400
| New | +$1.07M | 0.01% | 1289 |
|
Swiss National Bank's IPXL Position: Q2 2018 in Review
Swiss National Bank sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 122,900 shares — an estimated $2.39M sold.
Swiss National Bank first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $3.84M in Q4 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Swiss National Bank reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Swiss National Bank sold 122,900 Impax Laboratories, Inc. shares in Q2 2018, an estimated $2.39M.
- Swiss National Bank first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Swiss National Bank's Impax Laboratories, Inc. position peaked at $3.84M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Swiss National Bank's 13F filing for Q2 2018, filed 9 Aug 2018.